Abdominopelvic Fascial Release for Post-Cesarean Menstrual Pain and Scar Mobility

Official title

Abdominopelvic Fascial Release for Post-Cesarean Menstrual Pain and Scar Mobility: A Randomized Controlled Trial

Overview

The goal of this randomized controlled clinical trial is to determine whether adding abdominopelvic fascial release to a standardized stretching exercise program is more effective than stretching exercises alone in reducing menstrual pain in women following cesarean section. The study will enroll women aged 20 to 35 years with moderate to severe dysmenorrhea after cesarean delivery. Researchers will compare the effects of abdominopelvic fascial release combined with stretching exercises with stretching exercises alone on menstrual pain and scar mobility. Participants will be randomly assigned to one of two treatment groups, undergo assessments before and after the intervention period, and receive the assigned treatment according to the study protocol.

Detailed description

Cesarean section is one of the most commonly performed obstetric surgical procedures worldwide. Although it is frequently necessary to improve maternal and neonatal outcomes, postoperative healing may result in scar formation and fascial adhesions that can contribute to persistent menstrual pain, chronic pelvic pain, reduced scar mobility, abdominal tenderness, and impaired physical function. Fascial restrictions may alter tissue mobility and biomechanics, leading to pain and functional limitations.

Abdominopelvic fascial release is a manual therapy technique that applies sustained, low-load pressure to restricted fascial tissues to restore tissue mobility, improve fascial gliding, reduce pain, and enhance tissue function. Previous studies have demonstrated beneficial effects of fascial release on postoperative scar mobility, pain, and functional recovery; however, evidence regarding its effectiveness in women with menstrual pain following cesarean section remains limited.

The purpose of this prospective, randomized controlled trial is to evaluate whether the addition of abdominopelvic fascial release to a standardized stretching exercise program provides greater clinical benefit than a stretching exercise program alone in women with post-cesarean dysmenorrhea. Participants will be randomly assigned to one of two parallel groups and evaluated before and after completion of the intervention period using predefined clinical outcome measures.

The findings of this study are expected to provide evidence regarding the effectiveness of abdominopelvic fascial release as a non-pharmacological physical therapy intervention for reducing menstrual pain and improving scar mobility following cesarean section. The results may support the integration of fascial release techniques into postpartum rehabilitation programs and contribute to evidence-based physical therapy management for women with post-cesarean pain and scar-related dysfunction.

Interventions

• Other Abdominopelvic fascial Release
  Abdominopelvic fascial release is a manual therapy intervention designed to restore mobility of the abdominal and pelvic fascial tissues by applying sustained, low-load pressure to fascial restrictions. The treatment targets the cesarean scar, abdominal fascia, diaphragm, and psoas muscle to improve fascial mobility, reduce tissue restrictions, alleviate pain, and enhance tissue function. The intervention will be administered for 30 minutes per session, twice weekly for 2 weeks by a licensed phy

Primary outcome measures

• Change in Menstrual Pain Intensity [Time frame: Baseline and immediately after completion of the 4-week intervention period.]

Secondary outcome measures (3)

• Change in Cesarean Scar Mobility [Time frame: Baseline and immediately after completion of the 4-week intervention period.]
• Change in Dysmenorrhea Severity [Time frame: Baseline and immediately after completion of the 4-week intervention period.]
• Change in Pressure Pain Threshold [Time frame: Baseline and immediately after completion of the 4-week intervention period.]

Eligibility criteria

Inclusion criteria

• Females aged 20 to 35 years.
• History of at least one cesarean section.
• Moderate to severe primary or secondary dysmenorrhea following cesarean section.
• Regular menstrual cycles (21-35 days).
• Body mass index (BMI) between 18.5 and 29.9 kg/m².
• At least 6 months post-cesarean section to allow complete scar healing.
• Presence of restricted cesarean scar mobility on clinical examination.
• Willingness to participate and provide written informed consent.

Exclusion criteria

• Pregnancy or planned pregnancy during the study period.
• Previous abdominal or pelvic surgery other than cesarean section.
• Endometriosis, adenomyosis, uterine fibroids requiring treatment, or other diagnosed gynecological disorders associated with pelvic pain.
• Active pelvic inflammatory disease or genitourinary infection.
• Neurological or musculoskeletal disorders affecting pain perception or mobility.
• Systemic inflammatory, autoimmune, or connective tissue diseases.
• Current participation in another physical therapy or manual therapy program targeting the abdomen or pelvis.
• Use of corticosteroid injections or other invasive treatments to the abdominal or pelvic region within the previous 3 months.
• Contraindications to manual therapy.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation

Randomized

Model

Parallel assignment

Masking

Single blind

Primary purpose

Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07717983 · P.T.REC/012/006452

Primary sources (government registries)

• ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗